Additionally, TGF-β repressed the release of pro-inflammatory cytokines IFN-γ and TNF-α by lymphocytes, which are crucial mediators of anti-tumour effects, thus leading to a restricted response against grade III glioma cells [174]. The gene discussed is TGFB1; the disease is neoplasm.